Presentations & Publications
First-in-Human, First-in-Class, Phase 1B Preliminary Safety Data of VRON-0200, a Novel Checkpoint Modifier Containing Immunotherapy, for HBV Functional Cure
03/25/2024
Wong, GL et al.
Oral –
APASL 2024, Oral # O-0138